Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Microbix Biosystems Inc T.MBX

Alternate Symbol(s):  MBXBF

Microbix Biosystems Inc. develops and commercializes biological and technological solutions for human health and wellbeing. It enables the commercialization of diagnostic assays by making a range of critical ingredients and devices for the global diagnostics industry, notably antigens for immunoassays and its laboratory quality assessment products (QAPs) that support clinical lab proficiency... see more

Recent & Breaking News (TSX:MBX)

KOL Collaborators Present Microbix HPV Test-Control Results

GlobeNewswire 12 days ago

Microbix Presents Novel HSV Test Control at EMMD

GlobeNewswire October 7, 2024

Microbix Achieves Essential EU Regulatory Accreditations

GlobeNewswire October 3, 2024

Microbix Presenting at Muskoka Capital Conference

GlobeNewswire September 25, 2024

Microbix Reports Continued Strong Results for Q3 Fiscal 2024

GlobeNewswire August 14, 2024

Microbix Schedules Release of Results for Q3 Fiscal 2024

GlobeNewswire August 7, 2024

Microbix Presents HCV FLOQSwab® Format Test Control at ADLM

GlobeNewswire July 25, 2024

Microbix Hosts Minister Nina Tangri to Open Capacity Expansions

GlobeNewswire June 17, 2024

Microbix Advances Test-Ingredient Manufacturing Capabilities

GlobeNewswire June 4, 2024

Microbix Reports Strong Results for Q2 Fiscal 2024

GlobeNewswire May 15, 2024

Microbix Schedules Release of Results for Q2 Fiscal 2024

GlobeNewswire May 8, 2024

Microbix Collaborator Introduces New Lab Accreditation Program

GlobeNewswire April 25, 2024

Microbix Presenting at the 2024 Bloom Burton Conference

GlobeNewswire April 11, 2024

Microbix Announces Annual and Special Meeting Voting Results

GlobeNewswire April 1, 2024

Microbix's Clot-Buster Drug Project Advances

GlobeNewswire March 14, 2024

Microbix Unveils Test Controls for Head and Neck Cancer

GlobeNewswire March 11, 2024

Microbix Announces Issuance of Stock Options

GlobeNewswire February 26, 2024

Microbix Reports Record Results for Q1 Fiscal 2024

GlobeNewswire February 14, 2024

Microbix Schedules Release of Results for Q1 Fiscal 2024 

GlobeNewswire February 7, 2024

Microbix Unveils Test Control for Gastric Ulcer Disease Pathogen

GlobeNewswire February 6, 2024